Administrative Core to accelerate rare lung disease research and share information
Official title: Administration Core
Funded at University of Cincinnati · NIH-11453392 · Data updated 2026-11-12
A dedicated hub will organize and support rare lung disease research across clinics, patient groups, and researchers to speed up new knowledge and trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | September 5, 2026 |
| Project end | July 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $1,025,682 |
| NIH project number | 1U54HL188781-01 |
| Project ID | NIH-11453392 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with rare lung diseases who participate in consortium-led studies or are part of the Rare Lung Disease Clinic Network.
✕Less likely to help
Patients not directly involved in trials or who lack access to participating centers may not experience immediate benefits.
What this research studies
This grant funds an Administrative Core within the Rare Lung Diseases Consortium to coordinate clinical studies, data and biospecimens, patient advocacy, and collaboration among centers. It will help manage finances, communications, regulatory compliance, and education materials while enabling data sharing and stakeholder engagement. The aim is to identify biomarkers, target new therapies, and set the stage for future pivotal trials by aligning patient communities, clinicians, industry, and government partners.
Why it matters
Potential benefit: If successful, patients with rare lung diseases could benefit from faster access to new diagnostic tools and therapies and a more streamlined pathway to future clinical trials.
How similar studies have gone: Coordination cores like this have facilitated multi-center trials and data-sharing in other disease areas, showing improved trial readiness and data quality.
Where this research is happening
-
University of Cincinnati
Cincinnati, United States Active
Researchers
- Principal investigator: Mccormack, Francis Xavier — University of Cincinnati
- Study coordinator: Mccormack, Francis Xavier
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.